Metabolic and cardiovascular complications in HIV-infected patients: New challenges for a new age

Journal of Infectious Diseases

Volumn 205, Issue SUPPL. 3, 2012, Pages

  Gandhi, Rajesh T ^a,b   Sax, Paul E ^c   Grinspoon, Steven K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; INSULIN; LIPID; PROTEINASE INHIBITOR;

ATHEROSCLEROSIS; BODY COMPOSITION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DYSLIPIDEMIA; FRAMINGHAM RISK SCORE; HEALTH CARE ACCESS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INDIVIDUALIZATION; INSULIN RESISTANCE; MEDICAL DECISION MAKING; METABOLIC DISORDER; NOTE; PATIENT CARE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SYMPOSIUM; VIRUS REPLICATION;

AGING; ANTI-HIV AGENTS; BONE RESORPTION; CARDIOVASCULAR DISEASES; HIV INFECTIONS; HUMANS; METABOLIC DISEASES; RISK FACTORS;

EID: 84861050536     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis202     Document Type: Note

References (8)

1. Moore RD, Bartlett JG. Dramatic decline in the HIV-1 RNA level over calendar time in a large urban HIV practice. Clin Infect Dis 2011; 53:600-4.
2. Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 2011; 53:1120-6.
3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3:e442.
4. Thompson MA, Aberg JA, Cahn P, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA 2010; 304:321-33.
5. Hsue PY, Hunt PW, Schnell A, et al. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS 2009; 23:1059-67.
6. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 2011; 62:141-55.
7. Hunt PW, Martin JN, Sinclair E, et al. T cell activation is associated with lower CD41 T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 2003; 187:1534-43. (Pubitemid 36578959)
8. Robbins GK, Spritzler JG, Chan ES, et al. Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. Clin Infect Dis 2009; 48:350-61.